Cumberland Pharmaceuticals Inc. (CPIX)
NMS – Real Time Price. Currency in USD
4.53
-0.04 (-0.88%)
At close: May 12, 2026, 4:00 PM EDT
4.47
-0.06 (-1.32%)
After-hours: May 12, 2026, 7:04 PM EDT
Find any stock by ticker or company name

NMS – Real Time Price. Currency in USD
4.53
-0.04 (-0.88%)
At close: May 12, 2026, 4:00 PM EDT
4.47
-0.06 (-1.32%)
After-hours: May 12, 2026, 7:04 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 0.95 | 2.52 | 6.0 | |
| Quick ratio | 0.79 | 1.78 | 5.0 | |
| Debt to Equity | 0.47 | -0.80 | 7.0 | |
| Debt to Assets | 0.14 | 0.73 | 8.0 | |
| Interest coverage | -36.46 | -13.90 | 1.0 | |
| Weighted average score | 5.4 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 42M | 40M | 38M | 45M | 42M |
| Gross Profit | 28M | 29M | 26M | 34M | 30M |
| Operating Income | -6M | -6M | -7M | -3M | -7M |
| Net Income | -6M | -6M | -6M | -3M | -7M |
| EBITDA | -377K | -711K | -1M | 3M | -2M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | N/A | 1.0 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | N/A | N/A | 1.0 |
| Next year | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -33.23 | -132.65 | N/A | 12672.94 | 3.3 |
| Y/Y | -22.03 | -361.27 | N/A | -89.94 | 1.0 |
| 3y average | 2.49 | 13.44 | N/A | 223.44 | 5.5 |
| 5y average | 4.07 | -4.69 | N/A | 144.54 | 4.0 |
| Weighted average score | 3.5 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $11.0M significantly exceed its total debt $10.1M, ensuring strong financial flexibility
Total current assets $32.8M are just enough to cover Total current liabilities $34.5M, indicating tight liquidity
Debt-to-equity ratio (0.5) is well below the industry average (-0.8), showcasing prudent financial management
Interest coverage ratio (-36.5x) is dangerously low, suggesting debt repayment risks
The company generates positive free cash flow $387.0K, supporting its financial health